pharmaphorum

OCTOBER 11, 2022

Clarity on the characteristics of the category – for example, whether they are medical devices and, if so, which risk classification they would fall under – could be a big step forward in developing the sector and ensuring all products made available to patients are safe and effective.

121

121

ISPE

MAY 22, 2023

Four risk categories were developed, each with a series of risk factors relating to supply relative to demand. For the future, this suggests that WHO should be involved in political activity to minimize trade restrictions and to consider stewardship to make sure allocated stocks are properly dispensed and used.

Communication 98

Communication FDA 98

The FDA Law Blog

APRIL 8, 2024

Putting aside the question of whether the implementation of any program that requires Congressional action is feasible in the current political climate, we think the underlying premise of the White Paper falls short in both scope and in its description of factors that contribute to drug shortages. surgical robots, MRIs)?

FDA 59

FDA Hospitals Dosage Controlled Substances 59

pharmaphorum

OCTOBER 19, 2022

In fact, when equipped with the right technology, deskless workers (a category that includes home healthcare providers) are twice as likely to be very satisfied with their job and over 50% more likely to stay at their job for the next five years. What does CVS’s acquisition mean for the future of healthcare?

Communication 52

Communication Insurance Patient Care Vaccines 52

ISPE

OCTOBER 27, 2022

The term “DHTTs” is used to differentiate from the broader category of DHTs, but these two terms are often used interchangeably. However, this framework is limited because it does not consider DHTs that do not meet the definition of SaMD, nor does it provide recommendations on how category I products should be regulated. tools (DHTTs).

Health and Personal Care Stores 52

Health and Personal Care Stores FDA Communication Clinic Management 52

ISPE

OCTOBER 27, 2022

The term “DHTTs” is used to differentiate from the broader category of DHTs, but these two terms are often used interchangeably. However, this framework is limited because it does not consider DHTs that do not meet the definition of SaMD, nor does it provide recommendations on how category I products should be regulated. tools (DHTTs).

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52

PharmaShots

MARCH 9, 2023

In 2016, she received a special career-recognition award from Fundamed Foundation (a non-profit Spanish foundation) in the category of the most influential pharmaceutical executive from Spain over the past 15 years Education: Belén is an alumnus of the University of Alcala de Henares as an MS, Ph.D.,

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40